A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Maryam Fouladi Arzu Onar-Thomas Mark W. Kieran Marsha A. Moses |
| Publication date | July 19, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |